|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net income (loss) | ||
| Stock-based compensation | ||
| Net income (loss) from continuing operations | ||
| Adjustments to reconcile net operating income / (Loss) to net cash provided by / (used in) operating activities: | ||
| Accounts payable and accrued expenses | ||
| Depreciation | ||
| Amortization of employee incentive mortgages | ||
| Interest expense | ||
| Gain on debt forgiveness | ||
| (Increase) decrease in net accounts receivable | ||
| Prepaid expenses | ||
| (Increase) in other assets | ||
| Increase in accrued expenses | ||
| Increase in accounts payable | ||
| Increase/(decrease) in related party - short term debt | ||
| Increase/(decrease) in other current liabilities | ||
| Net cash (used) provided by operating activities | ||
| Cash flows from investing activities | ||
| Acquisition of fixed assets | ||
| Net cash (used) by investing activities | ||
| Cash Flows from financing activities | ||
| Proceeds from related party loans | ||
| Proceeds from issuance of convertible notes | ||
| Payment of recapitalization costs | ||
| (Repayments) of loans from Stockholders & related parties | ||
| Premiums paid for stockholders’ life insurance | ||
| Distributions to stockholders | ||
| Net cash (used)/provided by financing activities | ||
| Net increase/(decrease) in cash and cash Equivalents | ||
| Cash and cash equivalents at beginning of period | ||
| Cash and cash equivalents at end of period | ||
| Supplemental disclosure of cash flow information: | ||
| Income taxes paid | ||
| Common stock issued to reduce notes payable related parties | ||
| Noncash investing activities | ||
| Disposal of property and equipment | ||
| Noncash financing activities | ||
| Conversion of preferred stock to common stock | ||
| Warrants issued to holders of bridge loans | ||
| Warrants issued to holders of senior debt |
Loading...